Diabetes mellitus is a significant and escalating health concern across the Asia-Pacific region, necessitating innovative approaches to improve the quality of care and outcomes for individuals with diabetes. Continuous Glucose Monitoring (CGM) has emerged as a valuable tool in diabetes management, offering real-time data to optimize glycemic control and reduce the risk of complications. This abstract outlines key proposals and recommendations for the utilization of CGM technology within the AsiaPacific region. In response to the growing demand for guidelines on CGM use, this document summarizes the consensus reached among healthcare experts, researchers, and policymakers. The proposals encompass various facets of CGM implementation, including access, education, reimbursement, and integration with existing healthcare systems. The recommendations emphasize the need for increased accessibility to CGM technology for individuals with diabetes, regardless of their geographical location or socioeconomic status. Moreover, the document underscores the significance of healthcare professional education to ensure effective CGM usage and interpretation of data. Furthermore, this abstract highlights the importance of reimbursement policies that facilitate CGM adoption, making this transformative technology affordable and accessible. The integration of CGM data into existing healthcare systems is also discussed as a means to enhance patient care, improve clinical outcomes, and alleviate the burden of diabetes-related complications. By adhering to the proposals outlined in this abstract, stakeholders across the Asia-Pacific region can work collaboratively to advance diabetes management, reduce healthcare disparities, and improve the overall quality of life for individuals living with diabetes. These recommendations serve as a foundation for policymakers, healthcare providers, and researchers to develop comprehensive guidelines that promote the effective use of CGM technology in the region.
